DK1951395T3 - Fremgangsmåde til kvantitativ bestemmelse af poloxamerer - Google Patents

Fremgangsmåde til kvantitativ bestemmelse af poloxamerer

Info

Publication number
DK1951395T3
DK1951395T3 DK06793534.6T DK06793534T DK1951395T3 DK 1951395 T3 DK1951395 T3 DK 1951395T3 DK 06793534 T DK06793534 T DK 06793534T DK 1951395 T3 DK1951395 T3 DK 1951395T3
Authority
DK
Denmark
Prior art keywords
poloxamers
quantitative determination
protein
determination
relates
Prior art date
Application number
DK06793534.6T
Other languages
Danish (da)
English (en)
Inventor
Mara Rossi
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Priority claimed from PCT/EP2006/066383 external-priority patent/WO2007031566A1/en
Application granted granted Critical
Publication of DK1951395T3 publication Critical patent/DK1951395T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34—Size selective separation, e.g. size exclusion chromatography, gel filtration, permeation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
    • B01J20/28002—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their physical properties
    • B01J20/28004—Sorbent size or size distribution, e.g. particle size
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
    • B01J20/28054—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their surface properties or porosity
    • B01J20/28078—Pore diameter
    • B01J20/28083—Pore diameter being in the range 2-50 nm, i.e. mesopores
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Nanotechnology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Peptides Or Proteins (AREA)
DK06793534.6T 2005-09-14 2006-09-14 Fremgangsmåde til kvantitativ bestemmelse af poloxamerer DK1951395T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05108439 2005-09-14
US71764205P 2005-09-16 2005-09-16
PCT/EP2006/066383 WO2007031566A1 (en) 2005-09-14 2006-09-14 Method for the quantitative determination of poloxamers

Publications (1)

Publication Number Publication Date
DK1951395T3 true DK1951395T3 (da) 2012-04-02

Family

ID=35696020

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06793534.6T DK1951395T3 (da) 2005-09-14 2006-09-14 Fremgangsmåde til kvantitativ bestemmelse af poloxamerer

Country Status (10)

Country Link
JP (1) JP4897814B2 (xx)
CN (1) CN101262918B (xx)
AT (1) ATE547161T1 (xx)
BR (1) BRPI0615837A2 (xx)
DK (1) DK1951395T3 (xx)
ES (1) ES2378686T3 (xx)
PT (1) PT1951395E (xx)
SI (1) SI1951395T1 (xx)
UA (1) UA95461C2 (xx)
ZA (1) ZA200800253B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101343040B1 (ko) * 2010-12-28 2013-12-18 주식회사 삼양바이오팜 정제된 폴록사머 및 그의 정제방법
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
US20180024142A1 (en) * 2015-01-29 2018-01-25 Ares Trading S.A. Immunoassays for high positively charged proteins
WO2020211584A1 (zh) * 2019-04-19 2020-10-22 海正生物制药有限公司 组合物中泊洛沙姆188的检测方法
CN111289652A (zh) * 2020-03-16 2020-06-16 康立泰药业有限公司 注射剂中泊洛沙姆188的检测方法
CN111830168B (zh) * 2020-07-23 2022-07-22 吉林医药学院 一种泊洛沙姆的lc-hr-ms/ms定量分析方法
EP4442274A1 (en) 2021-12-01 2024-10-09 Chugai Seiyaku Kabushiki Kaisha Method for preparing antibody-containing formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4402263B2 (ja) * 1999-06-21 2010-01-20 パナソニック株式会社 クロマトグラフィー定量測定装置
TWI272948B (en) * 2003-05-01 2007-02-11 Ares Trading Sa HSA-free stabilized interferon liquid formulations
ATE384735T1 (de) * 2003-05-21 2008-02-15 Ares Trading Sa Verfahren zur chromatographischen analyse einer proteinlösung

Also Published As

Publication number Publication date
ZA200800253B (en) 2009-05-27
PT1951395E (pt) 2012-03-21
CN101262918A (zh) 2008-09-10
UA95461C2 (xx) 2011-08-10
CN101262918B (zh) 2011-03-23
ATE547161T1 (de) 2012-03-15
SI1951395T1 (sl) 2012-04-30
BRPI0615837A2 (pt) 2011-05-31
JP4897814B2 (ja) 2012-03-14
JP2009508132A (ja) 2009-02-26
ES2378686T3 (es) 2012-04-17

Similar Documents

Publication Publication Date Title
DK1951110T3 (da) Apparatur til måling af biologiske parametre
CY2016029I2 (el) Πρωτεϊνες συνδεσης αντιγονου προς προπρωτεϊνη κονβερτασης σουμπτιλισινης κεχιν τυπου 9(pcsk9)
DK1951395T3 (da) Fremgangsmåde til kvantitativ bestemmelse af poloxamerer
DK1608268T3 (da) Podepind til udtagning af biologiske pröver
DK2126586T3 (da) Direkte bestemmelse af vitamin D i serum eller plasma
DK2195466T3 (da) Fremgangsmåde til opbevaring af biologiske prøver
DK1869065T3 (da) Fremgangsmåde til kromatografi med svag opdeling
NO344992B1 (no) Anti-GM-CSF antistoffer og anvendelser for disse
DK1941026T3 (da) Fremgangsmåder til fremstilling af protein under anvendelse af anti-senescensforbindelser
FR2894157B1 (fr) Membrane permeable repoussant un ou plusieurs liquides
BRPI0911863A2 (pt) método para determinar a presença de um analito em uma amostra de estrutura queratinizada de um indivíduo.
DK1596192T3 (da) Fremgangsmåde til at separering af proteiner ved kapillær elektroforese og buffersammensætning til kapillær elektroforese
WO2006076687A3 (en) Elisa assays using prion-specific peptide reagents
DK2335042T3 (da) Fluidum-analyseanlæg og fremgangsmåde til drift af dette analyseanlæg
DK2183599T3 (da) Højfølsomme immunoassays og kits til bestemmelse af peptider og proteiner af biologisk interesse
DK2217376T3 (da) Kuvette og fremgangsmåde til anvendelse af denne kuvette
DK2118666T3 (da) Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve
DK1954713T3 (da) Modificerede grønfluorescerende proteiner og fremgangsmåder til anvendelse af samme
EA201171178A1 (ru) Устройство и способ для определения и количественного анализа аналитов, в частности, микотоксинов
DK2016421T3 (da) Reagenser og fremgangsmåder til detektering af proteiner ved hjælp af farvestoffer og dextriner
DK2094728T3 (da) Fremgangsmåder til anvendelse for human-adapterende monoklonale antistoffer
DK2249164T3 (da) Fremgangsmåde til at forarbejde en biologisk væske til analytbestemmelse
EA201500377A1 (ru) Способ обнаружения анализируемого вещества и определение его концентрации с использованием намагничиваемых гранул
DK2053048T3 (da) Fremgangsmåde til in situ kemisk sulfonering
DE602005007582D1 (de) In biologischen proben